Abstract:Aim : creation of a method for predicting the development of varicose veins of the lower extremities and its recurrence. Object and methods . 2 independent studies of patients with C2-C6 varicose veins of the lower extremities (CEAP-classifier) were conducted. In the first, with ultrasound diagnosis of the main veins of the lower extremities and genomic analysis of blood samples, 75 participants (men 20, women 55), mean age 43.7 ± 5.9 years. All patients were randomized into two groups: group I (n = 17) – with recurrent varicose veins; Group II (n = 58) – applied with varicose veins for the first time. The 2nd study involved 44 (men 10, women 34), mean age 55.5 ± 2.7 years. Similarly, patients were divided into groups – I (5) and II (39 people). All patients of the first stage of the study underwent real-time PCR with allele-specific primers to determine the A82G mutation in the MMP-12 gene (matrix metalloproteinase-12) and the second stage C634G in the VEGF-A gene (endothelial fibroblast growth factor – A). Results of the study . In patients of both groups I and II, having the MMP-12 gene in the heterozygous variant, dilatation of the tibial and popliteal veins was present (6.4 ± 0.3 mm and 10.7 ± 0.24 mm, respectively) with the presence reflux and slowing down the evacuation of blood from the deep venous system. In patients of group I, the MMP-12 gene was found in 80 % of cases, as A/A (homozygous) and A/G (heterozygous variation), while in group II only in 33.3 % of cases. Pearson's goodness-of-fit criterion χ2 = 10.4 (the critical value of the criterion is 6.63), p < 0.01. The frequency of recurrence of varicose veins and mutation of the MMP-12 gene according to the Spearman test was 1.0 with the number of degrees of freedom 23, p < 0.05. In the 2nd study, a correlation was found between groups I and II of patients with the C/C genotype (Pearson's coefficient χ2 = 0.79, p < 0.11) and a correlation in the duration of the disease between groups of patients with the C/C genotype (homozygous variation) and C /G (heterozygous variation) – Pearson correlation coefficient χ2 = 0.92 (p < 0.01). Conclusion . The revealed relationship between the MMP-12 gene polymorphism and the frequency of varicose vein recurrence is a predictor of the development of structural changes in the vein wall, and a mutation in the VEGF-A gene occurs with a long history of the disease.

Exploring the causal relationship between plasma lipids and varicose veins of lower extremity: A comprehensive two-sample Mendelian randomization study

Two-sample Mendelian randomization analysis reveals causal relationships between blood lipids and venous thromboembolism

Identification of potential drug targets for varicose veins: a Mendelian randomization analysis

Varicose Veins and Risk of Venous Thromboembolic Diseases: A Two-Sample-Based Mendelian Randomization Study

Exploring causal correlations between inflammatory cytokines and varicose veins: A Mendelian randomization analysis

A two-sample Mendelian randomization study of circulating lipids and deep venous thrombosis

Key Regulators of Angiogenesis and Inflammation Are Dysregulated in Patients with Varicose Veins

Aberrantly expressed lncRNAs in primary varicose great saphenous veins.

Sex Hormone-Binding Globulin Exerts Sex-Related Causal Effects on Lower Extremity Varicose Veins: Evidence from Gender-Stratified Mendelian Randomization.

Identifying potential drug targets for varicose veins through integration of GWAS and eQTL summary data

A bidirectional Mendelian randomized study of classical blood lipids and venous thrombosis

The effect of the A82G mutation in the MMP-12 gene and C634G mutation in the VEGF-A gene on the course of lower limb varicose veins and the risk of disease recurrence

Exome Sequencing Identifies Novel Genetic Variants Associated with Varicose Veins

Causal Effect of Serum Matrix Metalloproteinase Levels on Venous Thromboembolism: a Mendelian Randomization Study

Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study

A genome-wide association study for varicose veins

Weighted Gene Co-expression Network Analysis for RNA-Sequencing Data of the Varicose Veins Transcriptome.

Clinical and Genetic Determinants of Varicose Veins

The role of inflammatory proteins in regulating the impact of lipid specifications on deep venous thrombosis: a two sample and mediated Mendelian randomization study

Identification of biological significance of different stages of varicose vein development based on mRNA sequencing

Pathophysiology and Genetic Associations of Varicose Veins: A Narrative Review